Compugen CGEN
NASDAQ CGEN
$2.34 0.00 (-0.21%)
As of: Oct 2, 2026 · 9:30 AM EDT

Compugen (CGEN) Accumulated Expenses (2023 - 2026)

Updated

Compugen (CGEN) posted Accumulated Expenses of $5.26 million for Q2 2026, up 6.6% from $4.93 million a year earlier and up 30.4% from the prior quarter.

Analysis

Compugen (CGEN) Accumulated Expenses (2023 - 2026) Analysis & Trends

At the end of FY2025, Compugen's Accumulated Expenses came in at $5.68 million, up 9.8% from FY2024.

  • In prior years, Compugen's Accumulated Expenses was $5.17 million in FY2024 (-34.2%) and $7.86 million in FY2023.
  • Quarterly Accumulated Expenses has run from a low of $4.03 million in Q1 2026 to a high of $8.22 million in Q2 2024 over five years.
  • On a year-over-year basis, Accumulated Expenses increased in two of the last four quarters, with an average decline of 14.5%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Compugen 225.04 Mn -148.05 Mn -92,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.26 Mn
Mar 31, 2026 4.03 Mn
Dec 31, 2025 5.68 Mn
Jun 30, 2025 4.93 Mn
Dec 31, 2024 5.17 Mn
Jun 30, 2024 8.22 Mn
Dec 31, 2023 7.86 Mn
API Access

Compugen Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=CGEN&period=max&api_key=YOUR_API_KEY